Urine cell-based DNA methylation classifier for monitoring bladder cancer
暂无分享,去创建一个
L. Kiemeney | B. Czerniak | J. Witjes | C. Dinney | J. Schalken | A. G. van der Heijden | J. Lozano | A. Alcaraz | M. Ribal | B. Geavlete | Cindy C M van Rijt-van de Westerlo | L. Mengual | C. Ene | M. Ingelmo‐Torres | M. Baixauli | Cristian Moldoveanud | Cindy C. M. van Rijt-van de Westerlo
[1] H. Herr. Re: Marko Babjuk, Andreas Böhle, Maximilian Burger, et al. EAU Guidelines on Non-muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol 2017;71:447-61. , 2017, European urology.
[2] Maximilian Burger,et al. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. , 2017, European urology.
[3] B. Inman,et al. Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancer. , 2015, Urologic oncology.
[4] M. Peinado,et al. Wanderer, an interactive viewer to explore DNA methylation and gene expression data in human cancer , 2015, Epigenetics & Chromatin.
[5] Peter A. Jones,et al. A Panel of Three Markers Hyper- and Hypomethylated in Urine Sediments Accurately Predicts Bladder Cancer Recurrence , 2014, Clinical Cancer Research.
[6] M. Babjuk,et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. , 2013, European urology.
[7] P. Spiess,et al. Current and Emerging Bladder Cancer Urinary Biomarkers , 2011, TheScientificWorldJournal.
[8] Xavier Robin,et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.
[9] R. Lothe,et al. Three Epigenetic Biomarkers, GDF15, TMEFF2, and VIM, Accurately Predict Bladder Cancer from DNA-Based Analyses of Urine Samples , 2010, Clinical Cancer Research.
[10] Peter A. Jones,et al. Unique DNA methylation patterns distinguish noninvasive and invasive urothelial cancers and establish an epigenetic field defect in premalignant tissue. , 2010, Cancer research.
[11] L. de Leval,et al. Identification and validation of the methylated TWIST1 and NID2 genes through real-time methylation-specific polymerase chain reaction assays for the noninvasive detection of primary bladder cancer in urine samples. , 2010, European urology.
[12] L. Martínez-Piñeiro,et al. Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model. , 2009, The Journal of urology.
[13] B. Czerniak,et al. Aberrant Promoter Methylation of Multiple Genes during Pathogenesis of Bladder Cancer , 2008, Cancer Epidemiology Biomarkers & Prevention.
[14] M. Esteller. Epigenetics in cancer. , 2008, The New England journal of medicine.
[15] Tongyu Zhu,et al. A Novel Set of DNA Methylation Markers in Urine Sediments for Sensitive/Specific Detection of Bladder Cancer , 2007, Clinical Cancer Research.
[16] H. Grossman,et al. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study. , 2007, The Journal of urology.
[17] Unyime Nseyo,et al. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer. , 2007, The Journal of urology.
[18] J. Minna,et al. DNA methylation in health, disease, and cancer. , 2007, Current molecular medicine.
[19] D. Brutlag,et al. A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[20] R Y Ball,et al. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs , 2005 .
[21] I. Sesterhenn,et al. World health organization classifications of tumours. pathology and genetics of tumours of the urinary system and male genital organs , 2005 .
[22] Gerhard Jakse,et al. Guidelines on bladder cancer. , 2002, European urology.
[23] F. M. Brown,et al. URINE CYTOLOGY: Is it Still the Gold Standard for Screening? , 2000 .
[24] L. Sobin,et al. TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.
[25] L. Koss,et al. Interobserver and intraobserver differences in the diagnosis of urothelial cells. Comparison with classification by computer. , 1984, Analytical and quantitative cytology.